Variant report
Variant | nsv613321 |
---|---|
Chromosome Location | chr9:9724976-9758609 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000199347 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs568240685 | chr9:9729200-9729201 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs535690827 | chr9:9729215-9729216 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs553677300 | chr9:9729282-9729283 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs184119452 | chr9:9729285-9729286 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs147005749 | chr9:9729318-9729319 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs557859178 | chr9:9729324-9729325 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs576123875 | chr9:9729332-9729333 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs538708940 | chr9:9729343-9729344 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs117496832 | chr9:9729368-9729369 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs563242369 | chr9:9729388-9729389 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs74570207 | chr9:9729408-9729409 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs148070997 | chr9:9729430-9729431 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs7045439 | chr9:9729439-9729440 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs141733486 | chr9:9729450-9729451 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs559479870 | chr9:9729469-9729470 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs527849435 | chr9:9729480-9729481 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs552265847 | chr9:9729507-9729508 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs113404233 | chr9:9729519-9729520 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs555409056 | chr9:9729541-9729542 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs189521933 | chr9:9729545-9729546 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs111866075 | chr9:9729572-9729573 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs549905658 | chr9:9729602-9729603 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs568385684 | chr9:9729636-9729637 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs535396845 | chr9:9729641-9729642 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs150143061 | chr9:9729658-9729659 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs138190514 | chr9:9729695-9729696 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs539610263 | chr9:9729699-9729700 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs572111355 | chr9:9729751-9729752 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs181182034 | chr9:9729756-9729757 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs557922522 | chr9:9729769-9729770 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs527966516 | chr9:9729771-9729772 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs576185282 | chr9:9729774-9729775 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs543445180 | chr9:9729811-9729812 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs142876829 | chr9:9729867-9729868 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs573532774 | chr9:9729878-9729879 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs183901272 | chr9:9729886-9729887 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs188683633 | chr9:9729905-9729906 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs547805382 | chr9:9729920-9729921 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs527912806 | chr9:9729950-9729951 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs7026321 | chr9:9730031-9730032 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs570999278 | chr9:9730033-9730034 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs564285169 | chr9:9730048-9730049 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs146100317 | chr9:9730050-9730051 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs116717299 | chr9:9730084-9730085 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs568368368 | chr9:9730088-9730089 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs181538644 | chr9:9730092-9730093 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs140017259 | chr9:9730165-9730166 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs565964373 | chr9:9730179-9730180 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs114376512 | chr9:9730189-9730190 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs186060723 | chr9:9730200-9730201 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
abnormal development | 18461090 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lung cancer | 16740712 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 16608533 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Cervical cancer | 21063398 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Melanoma | 18172304 | CNVD |
Biliary cancer | 19435499 | CNVD |
Gastric cancer | 21586687 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myopathy | 18421352 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Acute lymphoblastic leukemia | 18957548 | CNVD |
Myeloproliferative neoplasm | 17564968 | CNVD |
Malignant meningioma | 17937814 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164919 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
small cell lung cancer | 20016488 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Lung cancer | 18438408 | CNVD |
XY gonadal dysgenesis | 20685758 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Oral cancer | 21386901 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 21785460 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21858162 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Autism | 22495311 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma | 19074898 | CNVD |
Malignant melanoma | 19074898 | CNVD |
Prostate cancer | 16573809 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Cancer | 20164920 | CNVD |
Lung cancer | 20668451 | CNVD |
Schizophrenia | 20838587 | CNVD |
Glioblastoma | 18772890 | CNVD |
Glioblastoma multiforme | 21390271 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Autism | 20858261 | CNVD |
Epilepsy | 20858261 | CNVD |
Mental retardation | 20858261 | CNVD |
Developmental delay | 21147756 | CNVD |
small cell lung cancer | 21764851 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Glioma | 17123091 | CNVD |
Lung cancer | 16773561 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Gastric cancer | 16891809 | CNVD |
Mental retardation | 17847001 | CNVD |
Cutaneous squamous cell carcinomas | 17420988 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pilocytic astrocytoma | 18670637 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Lung adenocarcinoma | 17982442 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:9729200-9731200 | Enhancers | HUES48 Cell Line | embryonic stem cell |
2 | chr9:9730200-9730600 | Enhancers | GM12878-XiMat | blood |
3 | chr9:9745200-9750800 | Enhancers | HUVEC | blood vessel |
4 | chr9:9747800-9748600 | Enhancers | Muscle Satellite Cultured Cells | -- |
5 | chr9:9748600-9752600 | Weak transcription | Muscle Satellite Cultured Cells | -- |
6 | chr9:9749600-9751000 | Enhancers | Fetal Kidney | kidney |
7 | chr9:9750600-9751200 | Enhancers | Liver | Liver |
8 | chr9:9751200-9751400 | Flanking Active TSS | Liver | Liver |
9 | chr9:9751400-9751600 | Enhancers | Liver | Liver |
10 | chr9:9751600-9751800 | Flanking Active TSS | Liver | Liver |
11 | chr9:9751800-9753600 | Enhancers | Liver | Liver |
12 | chr9:9752200-9754200 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
13 | chr9:9752200-9754800 | Enhancers | Rectal Mucosa Donor 31 | rectum |
14 | chr9:9752400-9752800 | Enhancers | Rectal Smooth Muscle | rectum |
15 | chr9:9752400-9753600 | Enhancers | HepG2 | liver |
16 | chr9:9752600-9753400 | Enhancers | Muscle Satellite Cultured Cells | -- |
17 | chr9:9752600-9754000 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
18 | chr9:9752800-9753400 | Enhancers | Adipose Nuclei | Adipose |
19 | chr9:9752800-9753400 | Enhancers | Sigmoid Colon | Sigmoid Colon |
20 | chr9:9752800-9753600 | Enhancers | Brain Hippocampus Middle | brain |
21 | chr9:9753400-9754400 | Weak transcription | Muscle Satellite Cultured Cells | -- |
22 | chr9:9754200-9754600 | Bivalent Enhancer | Foreskin Melanocyte Primary Cells skin03 | Skin |
23 | chr9:9754200-9755200 | Enhancers | Pancreatic Islets | Pancreatic Islet |
24 | chr9:9754400-9754600 | Enhancers | Muscle Satellite Cultured Cells | -- |
25 | chr9:9754400-9755000 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
26 | chr9:9756000-9756600 | Enhancers | Fetal Heart | heart |